New precision medicine venture gives Syngenis added firepower

The Sydney Morning Herald - Sep 23, 2026

Syngenis has joined Perron Institute and Gene S founders in a new precision-medicine venture that puts its integrated DNA and RNA biotech platform to work.

Read full article
More News
Business Vantage Views

Business Vantage Views is a dedicated online news network that brings to you the latest state of business and finance so that you can make the best judgment on investment and future planning.